Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | KDM1A | O60341 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.42 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.42 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL28725381 | 0.93 | MEN1 (0.56) | MEN1CYP2C19KMT2AKDM1AMAOB | |
| SCHEMBL30358225 | 0.93 | CCNB2 (0.44) | MEN1CYP2C19KMT2AKDM1AMAOB | |
| SCHEMBL23483030 | 0.91 | MEN1 (0.45) | MEN1CYP2C19KMT2AKDM1AMAOB | |
| SCHEMBL24109360 | 0.91 | MEN1 (0.45) | MEN1CYP2C19KMT2AKDM1AMAOB | |
| SCHEMBL15392903 | 0.89 | HSD17B10 (0.41) | MEN1CYP2C19KMT2AKDM1AMAOB | |
| SCHEMBL366283 | 0.85 | CYP2C19 (0.62) | MEN1CYP2C19KMT2ATSHR | |
| SCHEMBL9451016 | 0.83 | MEN1 (0.44) | MEN1CYP2C19KMT2ACCNB2CDK1 | |
| SCHEMBL12037308 | 0.80 | CCNB2 (0.41) | MEN1CYP2C19KMT2ACCNB2CDK1 | |
| SCHEMBL21338738 | 0.80 | CCNB2 (0.41) | MEN1CYP2C19KMT2ACCNB2CDK1 | |
| SCHEMBL14604223 | 0.80 | CCNB2 (0.41) | MEN1KMT2AKDM1AMAOBCCNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016109501-A1 | AMIDE COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS | KAROS PHARMACEUTICALS, INC. (US) | 2016-07-07 | — | — | WO | disclosed |
| US-8211820-B2 | Catalyst composition, and process for production of cross-coupling compound using the same | KYOTO UNIVERSITY (JP) | 2012-07-03 | — | — | US | disclosed |
| US-7799440-B2 | Organic electroluminescent device and host material of luminescent and hole-blocking material thereof | CHI MEI OPTOELECTRONICS CORP. (TW) | 2010-09-21 | — | — | US | disclosed |
| US-7799440-B2 | Organic electroluminescent device and host material of luminescent and hole-blocking material thereof | CHI MEI OPTOELECTRONICS CORP. (TW) | 2010-09-21 | — | — | US | disclosed |
| US-20100094018-A1 | CATALYST COMPOSITION, AND PROCESS FOR PRODUCTION OF CROSS-COUPLING COMPOUND USING THE SAME | KYOTO UNIVERSITY (JP) | 2010-04-15 | — | — | US | disclosed |
| US-20070015005-A1 | Organic electroluminescent device and host material of luminescent and hole-blocking material thereof | CHI MEI OPTOELECTRONICS CORP. (TW) | 2007-01-18 | — | — | US | disclosed |
| US-20070015005-A1 | Organic electroluminescent device and host material of luminescent and hole-blocking material thereof | CHI MEI OPTOELECTRONICS CORP. (TW) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094018-A1 | CATALYST COMPOSITION, AND PROCESS FOR PRODUCTION OF CROSS-COUPLING COMPOUND USING THE SAME | F11, PYM1, CA2 | MEN1 87/4885CYP2C19 154/4885KMT2A 909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.